Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Ratio (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Equity Ratio for 16 consecutive years, with 0.3 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 47.51% to 0.3 in Q4 2025 year-over-year; TTM through Nov 2025 was 0.3, a 47.51% decrease, with the full-year FY2025 number at 0.3, down 47.51% from a year prior.
  • Equity Ratio was 0.3 for Q4 2025 at Cryo Cell International, down from 0.23 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 15.97 in Q2 2021 to a low of 0.3 in Q4 2025.
  • A 5-year average of 0.72 and a median of 0.03 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 14475.78% in 2021, then tumbled 65489.26% in 2024.
  • Cryo Cell International's Equity Ratio stood at 0.07 in 2021, then plummeted by 134.06% to 0.02 in 2022, then crashed by 626.05% to 0.17 in 2023, then decreased by 19.81% to 0.2 in 2024, then crashed by 47.51% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Equity Ratio are 0.3 (Q4 2025), 0.23 (Q3 2025), and 0.24 (Q2 2025).